These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 25821641)
41. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Hynd MR; Scott HL; Dodd PR Neurochem Int; 2004 Oct; 45(5):583-95. PubMed ID: 15234100 [TBL] [Abstract][Full Text] [Related]
42. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. Tackenberg C; Brandt R J Neurosci; 2009 Nov; 29(46):14439-50. PubMed ID: 19923278 [TBL] [Abstract][Full Text] [Related]
43. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. Shankar GM; Bloodgood BL; Townsend M; Walsh DM; Selkoe DJ; Sabatini BL J Neurosci; 2007 Mar; 27(11):2866-75. PubMed ID: 17360908 [TBL] [Abstract][Full Text] [Related]
44. Systematic characterization of a non-transgenic Aβ Jiménez-Herrera R; Contreras A; Djebari S; Mulero-Franco J; Iborra-Lázaro G; Jeremic D; Navarro-López J; Jiménez-Díaz L Biol Sex Differ; 2023 Sep; 14(1):59. PubMed ID: 37716988 [TBL] [Abstract][Full Text] [Related]
45. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities. Li S; Stern AM Mol Psychiatry; 2022 Aug; 27(8):3182-3191. PubMed ID: 35484241 [TBL] [Abstract][Full Text] [Related]
46. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315 [TBL] [Abstract][Full Text] [Related]
47. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs. Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884 [TBL] [Abstract][Full Text] [Related]
48. Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease. Kurucu H; Colom-Cadena M; Davies C; Wilkins L; King D; Rose J; Tzioras M; Tulloch JH; Smith C; Spires-Jones TL Eur J Neurol; 2022 May; 29(5):1311-1323. PubMed ID: 34331352 [TBL] [Abstract][Full Text] [Related]
49. Brain amyloid-β oligomers in ageing and Alzheimer's disease. Lesné SE; Sherman MA; Grant M; Kuskowski M; Schneider JA; Bennett DA; Ashe KH Brain; 2013 May; 136(Pt 5):1383-98. PubMed ID: 23576130 [TBL] [Abstract][Full Text] [Related]
50. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2 Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L J Biol Chem; 2021; 296():100089. PubMed ID: 33434745 [TBL] [Abstract][Full Text] [Related]
51. Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss. Talantova M; Sanz-Blasco S; Zhang X; Xia P; Akhtar MW; Okamoto S; Dziewczapolski G; Nakamura T; Cao G; Pratt AE; Kang YJ; Tu S; Molokanova E; McKercher SR; Hires SA; Sason H; Stouffer DG; Buczynski MW; Solomon JP; Michael S; Powers ET; Kelly JW; Roberts A; Tong G; Fang-Newmeyer T; Parker J; Holland EA; Zhang D; Nakanishi N; Chen HS; Wolosker H; Wang Y; Parsons LH; Ambasudhan R; Masliah E; Heinemann SF; Piña-Crespo JC; Lipton SA Proc Natl Acad Sci U S A; 2013 Jul; 110(27):E2518-27. PubMed ID: 23776240 [TBL] [Abstract][Full Text] [Related]
52. Amyloid-β as a modulator of synaptic plasticity. Parihar MS; Brewer GJ J Alzheimers Dis; 2010; 22(3):741-63. PubMed ID: 20847424 [TBL] [Abstract][Full Text] [Related]
54. Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice. Ghosal K; Fan Q; Dawson HN; Pimplikar SW PLoS One; 2016; 11(7):e0159435. PubMed ID: 27459671 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss. Freund RK; Gibson ES; Potter H; Dell'Acqua ML Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206 [TBL] [Abstract][Full Text] [Related]
56. A role for astrocyte-derived amyloid β peptides in the degeneration of neurons in an animal model of temporal lobe epilepsy. Kodam A; Ourdev D; Maulik M; Hariharakrishnan J; Banerjee M; Wang Y; Kar S Brain Pathol; 2019 Jan; 29(1):28-44. PubMed ID: 29665128 [TBL] [Abstract][Full Text] [Related]
58. Slow excitotoxicity in Alzheimer's disease. Ong WY; Tanaka K; Dawe GS; Ittner LM; Farooqui AA J Alzheimers Dis; 2013; 35(4):643-68. PubMed ID: 23481689 [TBL] [Abstract][Full Text] [Related]
59. Alzheimer's Disease and Protein Kinases. Engin AB; Engin A Adv Exp Med Biol; 2021; 1275():285-321. PubMed ID: 33539020 [TBL] [Abstract][Full Text] [Related]